{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:30:14Z","timestamp":1792639814654,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T00:00:00Z","timestamp":1153958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T00:00:00Z","timestamp":1153958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1038\/sj.leu.2404306","type":"journal-article","created":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T10:50:15Z","timestamp":1153997415000},"page":"1533-1538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation"],"prefix":"10.1038","volume":"20","author":[{"given":"P","family":"Corradini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dodero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Valagussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Cortelazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,27]]},"reference":[{"key":"BF2404306_CR1","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Bri\u00e8re J, Haioun C et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood 1998; 92: 76\u201382.","journal-title":"Blood"},{"key":"BF2404306_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn J et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493\u20131498.","journal-title":"N Engl J Med"},{"key":"BF2404306_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa031770","volume":"350","author":"N Milpied","year":"2004","unstructured":"Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C et al. Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004; 350: 1287\u20131295.","journal-title":"N Engl J Med"},{"key":"BF2404306_CR4","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","volume":"19","author":"J Rodriguez","year":"2001","unstructured":"Rodriguez J, Munsell M, Yazji S, Hagemeister F, Younes A, Andersson B et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19: 3766\u20133770.","journal-title":"J Clin Oncol"},{"key":"BF2404306_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","volume":"120","author":"KW Song","year":"2003","unstructured":"Song KW, Mollee P, Keating A, Crump M . Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003; 120: 978\u2013985.","journal-title":"Br J Haematol"},{"key":"BF2404306_CR6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V87.4.1243.bloodjournal8741243","volume":"87","author":"R Fanin","year":"1996","unstructured":"Fanin R, Silvestri F, Geromin A, Infanti L, Sperotto A, Cerno M et al. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+\/\u2212 radiotherapy) and autologous bone marrow transplantation. Blood 1996; 87: 1243\u20131248.","journal-title":"Blood"},{"key":"BF2404306_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","volume":"23","author":"R Fanin","year":"1999","unstructured":"Fanin R, Ruiz de Elvira MC, Sperotto A, Baccarani M, Goldstone A . Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999; 23: 437\u2013442.","journal-title":"Bone Marrow Transplant"},{"key":"BF2404306_CR8","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1200\/JCO.2000.18.16.3025","volume":"16","author":"C Haioun","year":"2000","unstructured":"Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol \u2013 a Groupe d\u2019Etude des Lymphomes de l\u2019Adulte Study. J Clin Oncol 2000; 16: 3025\u20133030.","journal-title":"J Clin Oncol"},{"key":"BF2404306_CR9","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2002.02.125","volume":"20","author":"C Gisselbrecht","year":"2002","unstructured":"Gisselbrecht C, Lepage E, Molina T, Quesnel B, Fillet G, Lederlin P et al. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. J Clin Oncol 2002; 20: 2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"BF2404306_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/cncr.11610","volume":"98","author":"A Cuttica","year":"2003","unstructured":"Cuttica A, Zallio F, Ladetto M, Di Nicola M, Caracciolo D, Magni M et al. Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3. Cancer 2003; 98: 983\u2013992.","journal-title":"Cancer"},{"key":"BF2404306_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/sj.bmt.1703729","volume":"30","author":"C Tarella","year":"2002","unstructured":"Tarella C, Di Nicola M, Caracciolo D, Zallio F, Cuttica A, Omed\u00e8 P et al. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization. Bone Marrow Transplant 2002; 30: 725\u2013732.","journal-title":"Bone Marrow Transplant"},{"key":"BF2404306_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1200\/JCO.1997.15.2.491","volume":"15","author":"U Vitolo","year":"1997","unstructured":"Vitolo U, Cortellazzo S, Liberati AM, Freilone R, Falda M, Bertini M et al. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma. J Clin Oncol 1997; 15: 491\u2013498.","journal-title":"J Clin Oncol"},{"key":"BF2404306_CR13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/blood.V77.2.400.400","volume":"77","author":"S Siena","year":"1991","unstructured":"Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400\u2013409.","journal-title":"Blood"},{"key":"BF2404306_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2141.1995.tb05344.x","volume":"91","author":"C Tarella","year":"1995","unstructured":"Tarella C, Benedetti G, Caracciolo D, Castellino C, Cherasco C, Bondesan P et al. Both early and committed haematopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy+G-CSF. Br J Haematol 1995; 91: 535\u2013543.","journal-title":"Br J Haematol"},{"key":"BF2404306_CR15","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244\u20131253.","journal-title":"J Clin Oncol"},{"key":"BF2404306_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF2404306_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1365-2141.2001.02955.x","volume":"114","author":"S Cortelazzo","year":"2001","unstructured":"Cortelazzo S, Rambaldi A, Rossi A, Oldani E, Ghielmini M, Benedetti F et al. Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma. Br J Haematol 2001; 114: 333\u2013341.","journal-title":"Br J Haematol"},{"key":"BF2404306_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bmt.1704367","volume":"33","author":"E Jantunen","year":"2004","unstructured":"Jantunen E, Wiklund T, Juvonen E, Putkonen M, Lehtinen T, Kuittinen O et al. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplant. 2004; 33: 405\u2013410.","journal-title":"Bone Marrow Transplant."},{"key":"BF2404306_CR19","volume-title":"Cancer. Principles and Practice of Oncology","author":"MA Shipp","year":"1997","unstructured":"Shipp MA, Mauch PM, Harris NL . Non-Hodgkin's lymphomas. In: DeVita VT, Hellmann S, Rosenberg SA (eds). Cancer. Principles and Practice of Oncology. Lippincott-Raven: Philadelphia, PA, 1997, p 2165."},{"key":"BF2404306_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","volume":"27","author":"AK Blystad","year":"2001","unstructured":"Blystad AK, Enblad G, Kvaloy S, Berglund A, Delabie J, Holte H et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 2001; 27: 711\u2013716.","journal-title":"Bone Marrow Transplant"},{"key":"BF2404306_CR21","first-page":"1372","volume":"88","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A et al. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience. Haematologica 2003; 88: 1372\u20131377.","journal-title":"Haematologica"},{"key":"BF2404306_CR22","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1080\/10428190412331272749","volume":"45","author":"M Jagasia","year":"2004","unstructured":"Jagasia M, Morgan D, Goodman S, Hamilton K, Kinney M, Shyr Y et al. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leukaemia Lymphoma 2004; 45: 2261\u20132267.","journal-title":"Leukaemia Lymphoma"},{"key":"BF2404306_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.thj.6200359","volume":"5","author":"P Reimer","year":"2004","unstructured":"Reimer P, Schertlin T, Rudiger T, Geissinger E, Roth S, Kunzmann V et al. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study. Hematol J 2004; 5: 304\u2013311.","journal-title":"Hematol J"},{"key":"BF2404306_CR24","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM . Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467\u20131475.","journal-title":"Ann Oncol"},{"key":"BF2404306_CR25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the MD Anderson Cancer Center experience. Cancer 2005; 103: 2091\u20132098.","journal-title":"Cancer"},{"key":"BF2404306_CR26","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1182\/blood-2003-10-3389","volume":"103","author":"G Enblad","year":"2004","unstructured":"Enblad G, Hagberg H, Erlanson M, Lundin J, MacDonald AP, Repp R et al. A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 2004; 103: 2920\u20132924.","journal-title":"Blood"},{"key":"BF2404306_CR27","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M et al. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004; 22: 2172\u20132176.","journal-title":"J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404306","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:35:39Z","timestamp":1648784139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,27]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["BF2404306"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404306","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,27]]},"assertion":[{"value":"2 February 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}